Concepedia

Frank Barnhart

FB

Statistics

Publications

6

Citations

1.9K

H-Index

6

Active since

2000

Affiliations

Research Triangle Park Foundation(Current)

University of Alabama at Birmingham

GlaxoSmithKline (United States)

Manchester Academic Health Science Centre

GlaxoSmithKline (United Kingdom)

Frank Barnhart is an author at Research Triangle Park Foundation specializing in allergy, pulmonary disease, and medicine.

Top concepts

Publications per year

2000–2018

6

Publications

6

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T. Dransfield, Jean Bourbeau, Paul Jones et al. · The Lancet Respiratory Medicine · 2013 · 357 citations

, , +5

Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD

Courtney Crim, Mark T. Dransfield, Jean Bourbeau et al. · Annals of the American Thoracic Society · 2014 · 154 citations

The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD

Nicola A. Hanania, Gregory Feldman, W. Zachgo et al. · CHEST Journal · 2012 · 105 citations

Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma

William R. Lumry, Robert J. Noveck, Steven F. Weinstein et al. · Annals of Allergy Asthma & Immunology · 2001 · 26 citations

, , +5

1–5 of 6